In their many forms, biologically active substances − whether natural or synthetic in origin −, play an essential role in our everyday life. However, many problems are still to be solved, such as incurable diseases, resistant bacteria, reduced yields caused by climate change or environmentally friendly plant protection. Global change and societal challenges demand a flexible and broad response, in which bioactive compounds play a publicly little known but crucial role. However, no Leibniz Institute alone covers all aspects of bioactives development from their discovery to the clinic, field or consumer.

The Leibniz Research Network “Bioactive Compounds” involves Leibniz Institutes from four sections of the Leibniz Association. It provides a better integration and increases the value chain for its members, working on drug development, crop protection and related fields, well beyond the fragmented possibilities of single working groups or institutes.

The main goal of the proposed Leibniz Research Network is the further development of the subject-related communication platform, where the participating institutes, as well as external partners can exchange subject-based, methodological and technical expertise. This framework enables improved and expanded further development of methodical-technical competencies.

Spokesperson
Prof. Yvonne Mast
Leibniz-Institute DSMZ–German Collection of Microorganisms and Cell Cultures (DSMZ), Braunschweig
yvonne.mast@dsmz.de
Coordinator
Dr Anett Fischer
Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (HKI), Jena
T +49 3641 532-1377
annett.fischer@leibniz-hki.de
Spokeperson
Prof. Pierre Stallforth
Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute (HKI), Jena
T +49 3641 532-1527
pierre.stallforth@leibniz-hki.de